Endo Investors Seek Class Cert. In Opioid Stock-Drop Suit
Endo International PLC investors have asked a Pennsylvania federal court to grant them class certification in their suit claiming the pharmaceutical company knowingly misrepresented the safety of its opioid drug Opana,...To view the full article, register now.
Already a subscriber? Click here to view full article